0001415889-23-012532.txt : 20230823
0001415889-23-012532.hdr.sgml : 20230823
20230823130947
ACCESSION NUMBER: 0001415889-23-012532
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230821
FILED AS OF DATE: 20230823
DATE AS OF CHANGE: 20230823
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Anderson Cynthia Lynn
CENTRAL INDEX KEY: 0001989905
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37761
FILM NUMBER: 231196512
MAIL ADDRESS:
STREET 1: C/O VISTAGEN THERAPEUTICS, INC.
STREET 2: 343 ALLERTON AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vistagen Therapeutics, Inc.
CENTRAL INDEX KEY: 0001411685
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205093315
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-577-3600
MAIL ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: VistaGen Therapeutics, Inc.
DATE OF NAME CHANGE: 20110610
FORMER COMPANY:
FORMER CONFORMED NAME: Excaliber Enterprises, Ltd.
DATE OF NAME CHANGE: 20070906
4
1
form4-08232023_050842.xml
X0508
4
2023-08-21
0001411685
Vistagen Therapeutics, Inc.
VTGN
0001989905
Anderson Cynthia Lynn
C/O VISTAGEN THERAPEUTICS, INC.
343 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
CHIEF FINANCIAL OFFICER
0
Stock Option (right to buy)
5.34
2023-08-21
4
A
0
8333
0
A
2033-08-21
Common Stock
8333
8333
D
25% of the stock options vest on August 21, 2024 (the "Vesting Start Date") and 1/36th of the remaining number of shares vest monthly thereafter until all awarded shares are fully vested three (3) years after the Vesting Start Date.
The stock options were granted in connection with the Reporting Person's appointment as Chief Financial Officer and pursuant to the Issuer's 2019 Omnibus Equity Incentive Plan.
/s/ Cynthia L. Anderson
2023-08-23